NUP210 and primary biliary cholangitis: Overall, 39 of the 8,126 sera (0.48%, 95% CI: 0.34%-0.64%) were tested positive for AMA at IIF, AMA-M2, anti-gp210, or anti-sp100, that is all the known PBC-specific serum immunoreactivities [2,15].